Back to Search
Start Over
Influence of Insulin in the Ventromedial Hypothalamus on Pancreatic Glucagon Secretion In Vivo
- Source :
- Diabetes
- Publication Year :
- 2010
- Publisher :
- American Diabetes Association, 2010.
-
Abstract
- OBJECTIVE Insulin released by the β-cell is thought to act locally to regulate glucagon secretion. The possibility that insulin might also act centrally to modulate islet glucagon secretion has received little attention. RESEARCH DESIGN AND METHODS Initially the counterregulatory response to identical hypoglycemia was compared during intravenous insulin and phloridzin infusion in awake chronically catheterized nondiabetic rats. To explore whether the disparate glucagon responses seen were in part due to changes in ventromedial hypothalamus (VMH) exposure to insulin, bilateral guide cannulas were inserted to the level of the VMH and 8 days later rats received a VMH microinjection of either 1) anti-insulin affibody, 2) control affibody, 3) artificial extracellular fluid, 4) insulin (50 μU), 5) insulin receptor antagonist (S961), or 6) anti-insulin affibody plus a γ-aminobutyric acid A (GABAA) receptor agonist muscimol, prior to a hypoglycemic clamp or under baseline conditions. RESULTS As expected, insulin-induced hypoglycemia produced a threefold increase in plasma glucagon. However, the glucagon response was fourfold to fivefold greater when circulating insulin did not increase, despite equivalent hypoglycemia and C-peptide suppression. In contrast, epinephrine responses were not altered. The phloridzin-hypoglycemia induced glucagon increase was attenuated (40%) by VMH insulin microinjection. Conversely, local VMH blockade of insulin amplified glucagon twofold to threefold during insulin-induced hypoglycemia. Furthermore, local blockade of basal insulin levels or insulin receptors within the VMH caused an immediate twofold increase in fasting glucagon levels that was prevented by coinjection to the VMH of a GABAA receptor agonist. CONCLUSIONS Together, these data suggest that insulin's inhibitory effect on α-cell glucagon release is in part mediated at the level of the VMH under both normoglycemic and hypoglycemic conditions.
- Subjects :
- Male
medicine.medical_specialty
Complications
Endocrinology, Diabetes and Metabolism
medicine.medical_treatment
030209 endocrinology & metabolism
Biology
Hypoglycemia
Glucagon
Alpha cell
Rats, Sprague-Dawley
Mice
03 medical and health sciences
0302 clinical medicine
Insulin-Secreting Cells
Internal medicine
Internal Medicine
medicine
Animals
Insulin
Pancreas
Pancreatic hormone
030304 developmental biology
0303 health sciences
Glucagon secretion
3T3 Cells
medicine.disease
Rats
Insulin oscillation
Insulin receptor
Phlorhizin
Endocrinology
Ventromedial Hypothalamic Nucleus
biology.protein
Original Article
Proto-Oncogene Proteins c-akt
Subjects
Details
- ISSN :
- 1939327X and 00121797
- Volume :
- 59
- Database :
- OpenAIRE
- Journal :
- Diabetes
- Accession number :
- edsair.doi.dedup.....1b105c74280bf2949d80c58b7baaea73